Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 5;147B(5):571-8.
doi: 10.1002/ajmg.b.30590.

Longitudinal follow-up of late-onset Alzheimer disease families

R M Carney  1 , M A Slifer, P I Lin, P C Gaskell, W K Scott, C F Potocky, C M Hulette, K A Welsh-Bohmer, D E Schmechel, J M Vance, M A Pericak-Vance
Affiliations

Longitudinal follow-up of late-onset Alzheimer disease families

R M Carney et al. Am J Med Genet B Neuropsychiatr Genet. .

Abstract

Historically, data for genetic studies are collected at one time point. However, for diseases with late onset or with complex phenotypes, such as Alzheimer disease (AD), restricting diagnosis to a single ascertainment contact may not be sufficient. Affection status may change over time and some initial diagnoses may be inconclusive. Follow-up provides the opportunity to resolve these complications. However, to date, previous studies have not formally demonstrated that longitudinally re-contacting families is practical or productive. To update data initially collected for linkage analysis of late-onset Alzheimer disease (LOAD), we successfully re-contacted 63 of 81 (78%) multiplex families (two to 17 years after ascertainment). Clinical status changed for 73 of the 230 (32%) non-affected participants. Additionally, expanded family history identified 20 additional affected individuals to supplement the data set. Furthermore, fostering ongoing relationships with participating families helped recruit 101 affected participants into an autopsy and tissue donation program. Despite similar presentations, discordance between clinical diagnosis and neuropathologic diagnosis was observed in 28% of those with tissue diagnoses. Most of the families were successfully re-contacted, and significant refinement and supplementation of the data was achieved. We concluded that serial contact with longitudinal evaluation of families has significant implications for genetic analyses.

PubMed Disclaimer

Figures

Figure A
Figure A
Flowchart showing original dataset and clinical follow-up.
See this image and copyright information in PMC

References

    1. Bertram L, McQueen MB, Mullin K, Blacker E, Tanzi RE. Systematic meta-analyses of Alzheimer Disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17–32. - PubMed
    1. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE. Results of a high-resolution genome screen of 437 Alzheimer’s Disease families. Hum Mol Genet. 2003;12:23–32. - PubMed
    1. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1991;1:213–216. - PubMed
    1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. - PubMed
    1. Evans DA, Funkenstein DH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer’s Disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551–2556. - PubMed

Publication types

Substances